Document is current
Any future updates will be listed below
-
Authors
Wang, Xiaodie
Tian, Zhidan
Wang, Meng
Cai, Xiaoru
Yang, Shuyan
Zeng, Jianyao
Fang, Yuan
Bai, Xuesen
Wang, Pei
Sun, Yan
Guo, Chuanxin
Liu, Tao
Qian, Qijun https://orcid.org/0009-0008-6949-3866
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 21 July 2025
First Online: 11 August 2025
Declarations
:
: The studies involving humans were approved by Shanghai Milecell® Biotechnologies (Ethics Review No. 02 [2023]). Recruitments of healthy human blood donors were approved by Shanghai Liquan Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. The animal study was approved by Saifu New Drug Technology Service Co., LTD (IACUC NO. 2024-047-M, 2025-026-M). The study was conducted in accordance with the local legislation and institutional requirements.
: All authors have consented to the publication of this article.
: No conflicts of interest were declared.
